Study on Human Bioequivalence of Triprerelin Acetate for Injection

To investigate the pharmacokinetics of triprerelin acetate for injection and triprerelin acetate (Dufferin ®) for injection of reference preparation in patients with prostate cancer by single intramusculodynamic injection in fasting state, and to evaluate the bioequivalence of the two formulations in fasting state.

Trial Details

NCT ID
NCT06683066
Phase
PHASE1
Sponsor
The Affiliated Hospital of Qingdao University
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Triprorelin for injection
  • Diphereline
Locations (sample)
  • Qingdao, Shandong, China|36.06488,120.38042

Key Eligibility Criteria

  • 1\. Voluntarily participate in the test, and sign the informed consent, and fully understand the test content, process and possible adverse reactio…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →